We are live on
!
Find out more
SR
Syntax Research Portfolio holdings
AUM
$157M
1-Year Est. Return
16.51%
This Fund
S&P 500
This Quarter
Est. Return
+7.32%
1 Year Est. Return
+16.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
(-2.8%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-8.48%
Top 10 Holdings %
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$2.35M |
| 2 |
Zoetis
ZTS
|
+$2.21M |
| 3 |
Willis Towers Watson
WTW
|
+$2.17M |
| 4 |
Palo Alto Networks
PANW
|
+$2.16M |
| 5 |
Accenture
ACN
|
+$2.03M |
Top Sells
| 1 |
Nutrien
NTR
|
+$3.4M |
| 2 |
American Tower
AMT
|
+$3.32M |
| 3 |
Newmont
NEM
|
+$3.21M |
| 4 |
Americold
COLD
|
+$2.6M |
| 5 |
Merck
MRK
|
+$2.39M |
Sector Composition
| 1 | Technology | 19.94% |
| 2 | Healthcare | 5.03% |
| 3 | Industrials | 4.92% |
| 4 | Financials | 4.5% |
| 5 | Materials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Visa
V
$694B
| $451K | 0.32% |
1,270
+1
| +0.1% | +$349 |
|
52
Invesco QQQ Trust
QQQ
$466B
| $450K | 0.32% |
816
+1
| +0.1% | +$497 |
|
53
Alphabet (Google) Class A
GOOGL
$4.33T
| $392K | 0.28% |
2,226
+1
| +0% | +$164 |
|
54
Costco
COST
$419B
| $388K | 0.28% |
392
| – | – |
|
55
Vanguard Total Stock Market ETF
VTI
$658B
| $375K | 0.27% |
1,234
| – | – |
|
56
Intel
INTC
$487B
| $336K | 0.24% |
15,000
| – | – |
|
|
57
Merck
MRK
$315B
| $317K | 0.23% |
4,006
-30,028
| -88% | -$2.39M |
|
58
Home Depot
HD
$347B
| $298K | 0.21% |
812
+2
| +0.2% | +$724 |
|
59
TSMC
TSM
$2.13T
| $274K | 0.19% |
1,210
+4
| +0.3% | +$741 |
|
60
Paychex
PAYX
$40.8B
| $266K | 0.19% |
1,826
| – | – |
|
61
Bank of America
BAC
$432B
| $265K | 0.19% |
5,602
+7
| +0.1% | +$294 |
|
62
Vanguard Mid-Cap Growth ETF
VOT
$19.1B
| $238K | 0.17% |
837
| – | – |
|
63
Netflix
NFLX
$313B
| $234K | 0.17% |
1,750
| – | – |
|
64
Meta Platforms (Facebook)
META
$1.69T
| $181K | 0.13% |
245
| – | – |
|
65
Wells Fargo
WFC
$267B
| $163K | 0.12% |
2,036
| – | – |
|
66
Cisco
CSCO
$432B
| $160K | 0.11% |
2,306
-632
| -22% | -$38.8K |
|
67
Vanguard Dividend Appreciation ETF
VIG
$111B
| $155K | 0.11% |
758
| – | – |
|
68
Regeneron Pharmaceuticals
REGN
$71.2B
| $129K | 0.09% |
245
| – | – |
|
69
SAP
SAP
$189B
| $113K | 0.08% |
370
| – | – |
|
70
Consolidated Edison
ED
$41.4B
| $112K | 0.08% |
1,114
| – | – |
|
71
Eli Lilly
LLY
$1.04T
| $109K | 0.08% |
140
| – | – |
|
|
72
Newmont
NEM
$97B
| $109K | 0.08% |
1,872
-60,062
| -97% | -$3.21M |
|
73
Boston Properties
BXP
$11.3B
| $99.1K | 0.07% |
1,469
-237
| -14% | -$15.8K |
|
74
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
| $91K | 0.06% |
1,737
| – | – |
|
75
Phillips Edison & Co
PECO
$5.51B
| $88.5K | 0.06% |
2,527
| – | – |
|
Similar funds
BRWM
SF
AC
HEM
EP
CF
TPBG
CFG
Syntax Research's Q2 2025 Portfolio in Review
As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.
- Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
- Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
- Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
- Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
- Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
- Syntax Research opened 7 new positions and closed 12 in Q2 2025.
- Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.
Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.